CINECA IRIS Institutional Research Information System

ALLEGRA, Sarah
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.823
EU - Europa 2.070
AS - Asia 1.046
AF - Africa 25
SA - Sud America 24
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 6
Totale 7.004
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.795
IT - Italia 612
SG - Singapore 388
CN - Cina 371
IE - Irlanda 275
SE - Svezia 270
DK - Danimarca 235
DE - Germania 138
FR - Francia 119
AT - Austria 73
FI - Finlandia 72
UA - Ucraina 68
GB - Regno Unito 66
VN - Vietnam 65
IN - India 56
ID - Indonesia 41
KR - Corea 28
BE - Belgio 27
NL - Olanda 23
HK - Hong Kong 22
JP - Giappone 22
CA - Canada 21
PL - Polonia 21
ES - Italia 18
CZ - Repubblica Ceca 13
BR - Brasile 11
AU - Australia 10
GR - Grecia 10
TR - Turchia 9
RO - Romania 8
TW - Taiwan 8
IQ - Iraq 6
MX - Messico 6
ZA - Sudafrica 6
EG - Egitto 5
IR - Iran 5
PK - Pakistan 5
SI - Slovenia 5
UZ - Uzbekistan 5
CH - Svizzera 4
NG - Nigeria 4
TH - Thailandia 4
A1 - Anonimo 3
CL - Cile 3
EC - Ecuador 3
EU - Europa 3
PE - Perù 3
RU - Federazione Russa 3
SN - Senegal 3
AR - Argentina 2
BG - Bulgaria 2
CO - Colombia 2
KE - Kenya 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BW - Botswana 1
CY - Cipro 1
GE - Georgia 1
GH - Ghana 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
ME - Montenegro 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
PR - Porto Rico 1
TG - Togo 1
Totale 7.004
Salva come PNG Salva come JPEG
Città #
Ann Arbor 616
Chandler 571
Singapore 336
Dublin 274
Beijing 208
Santa Clara 188
Torino 158
Fairfield 154
Nyköping 138
Turin 133
Houston 128
Woodbridge 96
Ashburn 93
Wilmington 93
Columbus 89
Villeurbanne 88
Dearborn 87
Medford 78
Vienna 71
Princeton 59
Jacksonville 53
Cambridge 52
Seattle 45
Redwood City 40
Jakarta 39
Fremont 38
Dong Ket 34
Milan 34
Boardman 27
Guangzhou 23
Munich 22
New York 22
Brussels 21
Pisa 21
Warsaw 19
Nanjing 18
Los Angeles 14
Rome 14
Brno 13
Toronto 13
Boston 12
San Diego 11
Shanghai 11
Falls Church 10
Hefei 10
Hong Kong 10
Hebei 9
Catania 8
Hangzhou 8
Chicago 7
Jinan 7
Nanchang 7
Pune 7
Taipei 7
Washington 7
Mumbai 6
Norwalk 6
Nürnberg 6
Shenzhen 6
West Jordan 6
Esslingen am Neckar 5
Florence 5
Helsinki 5
Lappeenranta 5
Nuremberg 5
Philadelphia 5
Seoul 5
Verona 5
Zgornje Gorje 5
Abuja 4
Albano Laziale 4
Assago 4
Bari 4
Cape Town 4
Copenhagen 4
Delhi 4
Eygelshoven 4
Hyderabad 4
Kunming 4
London 4
Madrid 4
Mountain View 4
San Mateo 4
Silver Spring 4
Stockholm 4
The Bronx 4
Tianjin 4
Upper Marlboro 4
Aberdeen 3
Athens 3
Baghdad 3
Barolo 3
Boulder 3
Bucharest 3
Busto Arsizio 3
Chandigarh 3
Chengdu 3
Dallas 3
Guiyang 3
Islamabad 3
Totale 4.538
Salva come PNG Salva come JPEG
Nome #
Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children 397
Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms. 312
Identification of naïve HVC-4 patients who may be treated with pegylated-interferon and ribavirin according to IL28B polymorphisms. 242
Correlation between entecavir penetration in peripheral blood mononuclear cells and HBV DNA decay during treatment of HBeAg-negative chronic hepatitis B 195
Deferasirox pharmacokinetic and toxicity correlation in β-thalassaemia major treatment 193
VDR gene polymorphisms impact on anemia at 2 week of anti-HCV therapy: a possible mechanism for early RBV-induced anemia. 176
Role of pharmacogenetics on deferasirox AUC and efficacy 173
Deferasirox pharmacokinetics evaluation in a woman with hereditary haemochromatosis and heterozygous β-thalassaemia 168
Vitamin D pathway gene variants and HCV-2/3 therapy outcomes. 166
Intracellular and Plasma Trough Concentration and Pharmacogenetics of Telaprevir 164
UPLC-MS/MS method with automated on-line SPE for the isomer-specific quantification of the first-generation anti-HCV protease inhibitors in peripheral blood mononuclear cells 150
Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection 142
Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokinetics 139
"Procedimento per determinare glifosato e acido aminometilfosfonico in un campione" 135
Pharmacogenetics of ribavirin-induced anemia in HCV patients 134
Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children 125
VDR gene polymorphisms impact on anemia at 2 weeks of anti-HCV therapy: a possible mechanism for early RBV-induced anemia. 120
Ethambutol plasma and intracellular pharmacokinetics: A pharmacogenetic study 117
ABCB11 and ABCB1 gene polymorphisms impact on telaprevir pharmacokinetic at one month of therapy 109
Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma 106
Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children 104
Clinical relevance of the assessment of deferasirox trough levels in thalassemia patients 103
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes 103
A simple UHPLC-PDA method with a fast dilute-and-shot sample preparation for the quantification of canrenone and its prodrug spironolactone in human urine samples 98
Deferasirox pharmacokinetic evaluation in β-thalassaemia paediatric patients 96
Role of IL28-B polymorphisms in the treatment of chronic hepatitis B HBeAg-negative patients with peginterferon 95
UPLC-MS/MS method for the simultaneous quantification of anti-HBV nucleos(t)ides analogs: Entecavir, lamivudine, telbivudine and tenofovir in plasma of HBV infected patients 94
Deferasirox pharmacogenetic influence on pharmacokinetic, efficacy and toxicity in a cohort of pediatric patients 93
Deferasirox AUC efficacy cutoff and role of pharmacogenetics 91
Efavirenz pharmacogenetics in a cohort of Italian patients 89
Influence of single-nucleotide polymorphisms on deferasirox C-trough levels and effectiveness. 88
Intracellular accumulation of boceprevir according to plasma concentrations and pharmacogenetics 88
Influence of single-nucleotide polymorphisms on deferasirox C-trough levels and effectiveness 82
Clinical relevance of deferasirox trough levels in β-thalassemia patients 82
Pharmacogenomic influence on sepsis outcome in critically ill patients 82
NURR1 deficiency is associated to ADHD-like phenotypes in mice 82
Effect of ABCC2 and ABCG2 Gene Polymorphisms and CSF-to-Serum Albumin Ratio on Ceftriaxone Plasma and Cerebrospinal Fluid Concentrations 80
Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients 79
Influence of single nucleotide polymorphisms on deferasirox Ctrough levels and effectiveness: study on beta-talassemia major affected patients 76
The influence of sex, gender and age on COVID-19 data in the Piedmont region: the virus prefers men 76
The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients 74
Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants 74
Pharmacological and clinical evaluation of deferasirox formulations for treatment tailoring 73
A Common mdr1 Gene Polymorphism is Associated with Changes in Linezolid Clearance 71
EFFECT OF SEASONS ON FOUR ANTI-EPILEPTIC DRUGS PLASMA LEVELS 68
Role of pharmacogenetic in ribavirin outcome prediction and pharmacokinetics in an Italian cohort of HCV-1 and 4 patients 67
Pharmacogenetic of voriconazole antifungal agent in pediatric patients 67
GENDER ANALYSIS ON COVID-19 DATA IN PIEMONTE: THE VIRUS PREFERS MEN 67
Sex Differences on Mitotane Concentration and Treatment Outcome in Patients with Adrenocortical Carcinoma 62
DEVELOPMENT AND VALIDATION OF A HPLC METHOD FOR OROTIC ACID AND OROTIDINE 5’-MONOPHOSPHATE DETECTION IN HUMAN PLASMA AND URINE 62
SEX DIFFERENCES ON MITOTANE CONCENTRATION AND TREATMENT OUTCOME IN PATIENTS WITH ADRENOCORTICAL CARCINOMA 61
Tyrosine kinase inhibitors: the role of pharmacokinetics and pharmacogenetics 61
Evaluation of intracellular and plasma pharmacokinetics, pharmacogenetics and clinical features in HBV e antigen-negative patients treated with entecavir. 60
Pharmacokinetics of linezolid in critically ill patients: impact of continuous venovenous haemofiltration 55
NURR1-deficient mice have age- and sex-specific behavioral phenotypes 54
Different Underlying Mechanism Might Explain the Absence of a Significant Difference in Area Under the Concentration-Time Curve of Linezolid for Different ABCB1 Genotypes 54
Precision medicine for HIV: where are we? 54
Effect of Gender and Age on Voriconazole Trough Concentrations in Italian Adult Patients 52
Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cryoglobulinemia and response to PEG-IFN and ribavirin treatment 51
Procedimento per determinare glifosato e acido aminometilfosfonico in un campione 50
Vessels Encapsulating Tumor Clusters (VETC) Is a Powerful Predictor of Aggressive Hepatocellular Carcinoma 49
Sex-Based Evaluation of Lipid Profile in Postoperative Adjuvant Mitotane Treatment for Adrenocortical Carcinoma 47
GENDER-SPECIFIC SIDE EFFECTS OF CHEMOTHERAPY IN PANCREATIC CANCER PATIENTS 43
La fluidità dei confini: il diritto alla salute ha un genere? 42
Self-Completion Questionnaire on Sleep Evaluation in Patients Undergoing Oxaliplatin Therapy: An Observational Study 37
The Influence of sex, gender, and age on COVID-19 data in the Piedmont Region (Northwest Italy): the virus prefers men 36
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes 35
Determinazione del glifosato su matrici organiche e inorganiche: valutazione degli effetti tossici 34
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma 33
Mass Spectrometry approach to quantifying orotic acid and its metabolites in urine 31
A convenient method for extraction and analysis with high-pressure liquid chromatography of cathecholamine neurotransmitters in plasma and brain samples of mice 31
Sex differences on mitotane concentration and treatment outcome in patients with adrenocortical carcinoma 28
Influence of seasonal variation and gender on anti-epileptic drugs pharmacokinetics 26
Gender analysis on COVID-19 data in piemonte: the virus prefers men 26
Colorectal cancer chemotherapy: can sex-specific disparities impact on drug toxicities? 25
Cancer Genetics and Clinical Research 25
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma 23
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma 23
“New standardised procedure to extract glyphosate and aminomethylphosphonic acid (ampa) from organic and inorganic matrices: toward a practical kit for hplc-uv detection” 23
Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children 22
Development and validation of an HPLC method for orotic acid and orotidine 5’-monophosphate detection in human plasma and urine 22
Phytotherapy and Drugs: Can Their Interactions Increase Side Effects in Cancer Patients?” 21
Effect of seasons on four anti-epileptic drugs plasma levels 21
A convenient method for extraction and analysis with High-Pressure Liquid Chromatography of catecholamine neurotransmitters in plasma and brain samples of mice 21
Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Comparison of Deferasirox Formulations for Treatment Tailoring 19
Age and Sex-Related Differences in Teicoplanine Isoform Concentrations in SARS-CoV-2 Patients 19
The Strange Case of Orotic Acid: the different expression of pyrimidines biosynthesis in heathy males and females 18
Gender differences in five different drug pharmacokinetics 17
COVID-19 Prevention and Treatment 15
Evaluation of sex differences in preclinical pharmacology re-search: how far still to go? 13
Gender Medicine and Pharmacology 12
Posaconazole plasma concentrations in children and adolescent 11
Pharmacokinetics of four tyrosine kinase inhibitors in adult and paediatric chronic myeloid leukaemia patients 11
Hydroxyurea pharmacokinetic evaluation in Sickle Cell Disease patients. 10
COVID-19 Prevention and Treatment-2nd edition 7
PHARMACOKINETICS AND PHARMACOGENETICS OF DEFERASIROX FOR IRON OVERLOAD TREATMENT IN BETA-THALASSAEMIA PATIENTS 6
COVID-19 Prevention and Treatment 2
Totale 7.365
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.361
article - articoli 0
book - libri 0
conference - conferenze 4.284
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.645
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020731 0 0 0 0 77 176 81 52 78 89 82 96
2020/2021711 59 49 32 42 57 49 30 16 76 29 132 140
2021/20221.239 69 78 105 103 85 125 88 72 54 62 227 171
2022/20231.648 125 142 52 143 177 408 101 123 180 41 113 43
2023/2024744 101 127 68 48 63 42 21 32 18 43 60 121
2024/2025907 39 128 99 205 436 0 0 0 0 0 0 0
Totale 7.365